Search Results

53 articles with title/keywords/abstract containing Therapeutic-substitution

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Once-daily atazanavir/ritonavir for HIV-associated lipodystrophy

Source: Reactions, Volume 1, Number 1216, 2008-08-23 , pp. 4-4(1)

Publisher: Adis International

Once-daily atazanavir/ritonavir for HIV-associated lipodystrophy

Source: Inpharma, Volume 1, Number 1652, 2008-08-23 , pp. 16-16(1)

Publisher: Adis International

SSRI-to-duloxetine switch a good move in MDD

Source: Inpharma, Volume 1, Number 1628, 2008-03-08 , pp. 13-13(1)

Publisher: Adis International

Asthma patients breathe easy with salmeterol/fluticasone

Source: Inpharma, Volume 1, Number 1589, 2007-05-26 , pp. 9-9(1)

Publisher: Adis International

Anastrozole switch: "valuable option" in breast cancer

Source: Inpharma, Volume 1, Number 1500, 2005-08-13 , pp. 13-13(1)

Publisher: Adis International

Sirolimus inhibits the progression of Kaposi's sarcoma in renal transplant recipients while maintaining immunosuppression

Source: Inpharma, Volume 1, Number 1482, 2005-04-09 , pp. 13-13(1)

Publisher: Adis International

Calcineurin-inhibitor nephrotoxicity reduced by sirolimus withdrawal

Source: Reactions, Volume 1, Number 1031, 2004-12-11 , pp. 5-5(1)

Publisher: Adis International

"Considerable interest" sparked by opioid switching analysis

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 468, 2004-12-18 , pp. 5-5(1)

Publisher: Adis International

Sirolimus withdrawal improves calcineurin-inhibitor nephrotoxicity

Source: Inpharma, Volume 1, Number 1466, 2004-12-04 , pp. 8-8(1)

Publisher: Adis International

Economic implications of long-acting opioid switching

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 447, 2004 , pp. 13-13(1)

Publisher: Adis International

Switch to COX-2 inhibitors cautious in Ireland

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 443, 2003 , pp. 5-5(1)

Publisher: Adis International

Amlodipine to felodipine switch produces modest cost savings

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 440, 2003 , pp. 6-6(1)

Publisher: Adis International

Tacrolimus: neuropsychological disorders in children and adolescents

Source: Reactions, Volume 1, Number 957, 2003 , pp. 5-5(1)

Publisher: Adis International

Pharmacist-run conversion programme cuts hospital costs, LOS

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 393, 2002 , pp. 5-5(1)

Publisher: Adis International

Amlodipine formulary switch increases overall drug costs

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 379, 2002 , pp. 9-9(1)

Publisher: Adis International

Drug formulary switches increase health risks in the US

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 373, 2002 , pp. 8-8(1)

Publisher: Adis International

A formulary change which eliminated the use of all third-generation cephalosporins at a US hospital

Source: Inpharma, Volume 1, Number 1339, 2002 , pp. 6-6(1)

Publisher: Adis International

A formulary change which eliminated the use of all third-generation cephalosporins at a US hospital

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 364, 2002 , pp. 7-7(1)

Publisher: Adis International

Therapeutic substitution common in US hospitals

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 361, 2002 , pp. 9-9(1)

Publisher: Adis International

Formulary switch to sargramostim cost saving

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 362, 2002 , pp. 6-6(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A